Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Alpha particle emission is a form of high linear energy transfer (LET) ionizing radiation that causes complex and highly localized DNA damage, particularly DNA double-strand breaks (DSBs), through ionization events along very short tracks within exposed cells[2][3][5][7]. The mechanism of DNA damage by alpha particles is both direct (physical disruption of DNA structure) and indirect (generation of reactive oxygen species and other radicals causing further chemical DNA damage)[5][6]. This results in characteristic damage signatures, such as dense clusters of DSBs that are challenging for cellular repair systems and often lead to apoptosis, cell death, or chromosomal aberrations[2][3][6]. While the site of action is DNA in cells rather than a single molecular target like a receptor or enzyme, this mechanism underpins the cytotoxic effects of targeted alpha therapy (e.g., Radium-223), which is leveraged therapeutically, especially against cancer, because it is potent against both dividing and non-dividing tumor cells[2][3][5]. However, the concept "Radiation-induced DNA damage via alpha particle emission" does not refer to a discrete molecular entity, protein, or receptor but rather to a biological effect or process; thus, it does not fit conventional "therapeutic target" categories (like receptors, enzymes, or ion channels). It is important to note this distinction when structuring pharmacological target information[5][6].
Induction of clustered DNA double-strand breaks (DSBs); Oxidative DNA damage via ionization and free radicals; Chromosomal fragmentation and misrepair
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Radiation-induced DNA damage by alpha particle emission.